Bethanie Parsons vividly remembers the moment she realised something had gone terribly wrong during the birth of her first ...

Boston Scientific acquires Valencia Technologies' eCoin bladder dysfunction device, expanding into the $30M+ overactive ...

The deal would set up Boston Scientific to compete directly with Medtronic in the market for neuromodulation devices that ...

Acquisition to expand urology offerings for people living with overactive bladder MARLBOROUGH, Mass., Jan. 12, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: ...

Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Valencia Technologies Corporation, a privately held medical technology company focused ...

Boston Scientific is buying up privately owned medtech Valencia Technologies for its implantable device aimed at helping ...

MOUNTAIN VIEW , CA, UNITED STATES, January 7, 2026 /EINPresswire.com/ -- Renaissance Healthcare for Women, led by ...

Johnson & Johnson gained Inlexzo, formerly known as TAR-200, when it acquired privately held Taris Biomedical in 2019. The deal gave J&J a treatment it says could change way the “non-muscle invasive” ...

The US Food and Drug Administration (FDA) has granted 510 (k) clearance for BlueWind Medical, Ltd.’s enhanced Revi® implantable tibial neuromodulator for treatment of urgency urinary incontinence (UUI ...

Urogynecologist Judy Yeh, MD, FACOG and the Tift Regional Medical Center operating room team conducted the first Altaviva ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for ...

Market OverviewThe global ostomy devices market is projected to grow at a healthy rate of 4–5% and is expected to reach approximately USD 3.2 billion by 2026. This steady expansion is driven by rising ...